PGLYRP3 and atopic eczema: To determine whether IL-17 is required for the high sensitivity of Pglyrp3−/− mice to atopic dermatitis, we compared the severity of ear inflammation in oxazolone-treated Pglyrp3−/− mice in which IL-17 activity was inhibited with neutralizing anti-IL-17 mAb.